Blogs (4)

BLU2864 is An Orally Active PRKACA Kinase Inhibitor

BLU2864 is an orally active ATP-competitive PRKACA inhibitor. BLU2864 can be used in cancer and polycystic kidney disease research.
Vorasidenib (AG-881) is an Orally Available, Brain Penetrant and dual mIDH1/2 Inhibitor

Vorasidenib is an orally available, brain penetrant second-generation dual mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2) inhibitor.
FAPI-46 is a Quinoline-Based Fibroblast Activation Protein (FAP)-Targeted Radiotracer

FAPI-46 is a quinoline-based FAP-targeted radiotracer. FAPI-46 has higher tumor uptake and prolonged tumor accumulation.
CRT0044876 is a Potent and Selective APE1 Inhibitor

CRT0044876 is a potent and selective APE1 inhibitor. CRT0044876 inhibits the AP endonuclease, 3′-phosphodiesterase and 3′-phosphatase activities of APE1.

Name
Email *

	Sorry, but the email address you supplied was invalid.